Human FcγRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof
AssigneeNew York Society for the Ruptured and Crippled Maintaining the Hospital for Special Surgery
InventorLuminita Pricop
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for predicting the likelihood of development of systemic lupus erythematosus (SLE) in an individual, which comprise determining the sequence at one or more polymorphic positions within the human genes encoding FcγRIIB. The invention also provides isolated nucleic acids encoding FcγRIIB polymorphisms, nucleic acid probes that hybridize to polymorphic positions and kits for the prediction of SLE status.
Claims7
A method for assessing whether an individual has or is susceptible to development of systemic lupus erythematosus comprising comparing
- (a) a test polymorphic pattern comprising at least one polymorphic position within an FcγRIIB promoter gene of the individual, with
- (b) a reference polymorphic pattern derived from a population of individuals having systemic lupus erythematosus. wherein the reference polymorphic pattern comprises a C residue at position −385 and/or an A residue at position −119;
- and
- (c) concluding whether the individual is susceptible to development of systemic lupus erythematosus wherein identity between at least one polymorphism included in the test polymorphic pattern and at least one polymorphism included in the reference polymorphic pattern indicates that the individual has or is susceptible to development of systemic lupus erythematosus.
Dependencies are inferred from the claim text.